Skip to main content

Table 3 Independent predictors of health utilities in Japanese patients (p < 0.05 only)

From: Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials

Predictor

Beta

Std. Err.

p

Age ≥ 60 years

−4.18

0.94

<0.0001

Male gender

3.15

0.94

<0.0001

Insomnia

−6.10

1.38

<0.0001

Treatment regimen (interacted with time – end of treatment only)

LDV/SOF

reference

LDV/SOF + RBV

−5.33

1.32

<0.0001

SOF + RBV

−4.06

1.36

0.0030